drugset
drugset / Trial / NCT02803268

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

NCT02803268 ↗

Phase 1 Completed 24 enrolled Tanabe Pharma Corporation
RandomizedParallel-groupDouble-blindOther

Summary

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

Timeline

Start
2016-06
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Elismetrep Small molecule — —

Indications

No indication recorded.